Speakers

Anthony Berloco

Vice President, Controller

Genmab

Bob Decker CPA, CMA

Corporate Controller & Chief Accounting Officer

Johnson & Johnson

Chris Kimtis

Senior Director, Corporate Financial Reporting

Bristol Myers Squibb

Christian Alaia

Senior Director, Financial Planning & Analysis

Immuneering Corporation

Erica Vandell-DeMarco, CPA

Managing Director

The Siegfried Group, LLP

Erin Burkhart

Senior Vice President, Controller & Chief Accounting Officer

Gilead Sciences

Jenni Humes

Chief Accounting Officer

Roivant

Jeremy Lantz

Executive Director, Controller

Lilly USA, Eli Lilly and Company

Jess Montler

Executive Director, Technical Accounting

Bristol Myers Squibb

Josh Richards

Head, US Accounting & Reporting

Sandoz

Kevin MacKay

Vice President, Global Technical Accounting Advisory Services & Policy

Pfizer

Kevin Nee

Senior Vice President, Finance

Collegium Pharmaceutical

Laura Klein

Director, Consolidations and Financial Reporting

Bristol Myers Squibb

Maricel Apuli

Chief Accounting Officer

BridgeBio

Matthew Busch

Vice President of Finance, Chief Accounting Officer

Amgen

Paula George

Director, Assistant Controller

Immuneering Corporation

Scott Godsoe

Executive Director, Assistant Corporate Controller

Vertex Pharmaceuticals

Sean Godbout

Chief Accounting Officer, Global Controller

Biogen

Stephen Rivera

Former Vice President, Global Technical Accounting Advisory Services & Policy

Johnson & Johnson

Stephen Sebastian

Executive Director, Corporate Controller

Immuneering Corporation

Timothy Kocses

Executive Director, US Commercial Controller

Bristol Myers Squibb